Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F48Q9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,914
Award facts
- Contract value 100% obligated
- $10,914.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,914.09 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of January 29, 2026. The contract utilizes a firm fixed-price structure and was not set aside for any specific business category. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle valued through December 2031 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
The delivery order reflects routine pharmaceutical procurement under DLA's medical supply chain operations, which supports military treatment facilities and veteran healthcare programs. Eliquis, an anticoagulant medication commonly prescribed for stroke prevention and blood clot treatment, is part of the extensive specialty medication portfolio that AmerisourceBergen supplies through its federal contracts. As a non-set-aside competitive award, this order demonstrates AmerisourceBergen's continued capability to meet federal pharmaceutical requirements in open competition, consistent with its established role as a critical vendor for Department of Defense medical supply needs.
Quick answers
Who was awarded contract SPE2DR26F48Q9?
SPE2DR26F48Q9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F48Q9 worth?
The government has obligated $10,914 on SPE2DR26F48Q9.
Is contract SPE2DR26F48Q9 an order under another contract?
Yes. SPE2DR26F48Q9 is a delivery order under SPE2DR25D3304, an indefinite delivery contract.
Was contract SPE2DR26F48Q9 competed?
The extent of competition for SPE2DR26F48Q9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award